DEFINITIVE PROXY STATEMENT

Company

Protalix BioTherapeutics, Inc.

Filed

September 19, 2011

Period of Report

November 7, 2011

Accession Number

0001144204-11-053749

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →